Resultados de la búsqueda 141-150 of 11359 for Raised white cell count
... number of PPGL. Long-Term Follow-Up Of Patients ... high and very high risk relapsed FHWT (those ... cell would result in T cell cytotoxic killing.
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...
H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of increasing immune response and protecting against breast cancer. A Study ...
... high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of ...
... cells by blocking some of the enzymes needed for cell growth. Olaparib ... High-Risk Neuroblastoma Or Ganglioneuroblastoma. Rochester, Minn. Despite recent ...
This is a peripheral blood Collection Protocol to study the T-cell ... high (80-90%) frequency of MUC1 ... count ≥ 1,500 /microliter, and platelets ...
This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.
... cell would result in T cell cytotoxic killing. A Study To Evaluate ... high and very high risk relapsed FHWT (those treated with 3 or more drugs for ...
This may lead to an increased risk of serious infections requiring hospitalization and an increased risk of secondary non-blood-based (hematologic) cancers.
H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of increasing immune response and protecting against breast cancer.
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?